In summary, based on our findings, we conclude that the loss of XRCC1 expression was significantly correlated with the progression of ccRCC and was related to worse ccRCC patient survival but was not an independent predictor of survival in ccRCC patients. This evidence concerns the gene XRCC1 and nonpapillary renal cell carcinoma.